Search

everythinglearnresearchcommunity

for

Search:↓

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Ensure respectful and inclusive care for transgender and gender-diverse patients during surgery.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Transgender individuals face more barriers and less autonomy in surgical body modifications compared to cisgender individuals.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

Oral minoxidil can effectively treat hair loss in transgender and gender-diverse individuals.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Facial aesthetic procedures improve quality of life for transgender individuals.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Sublingual minoxidil significantly improves hair growth in transgender individuals on testosterone therapy.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

Many transgender men on testosterone therapy experience hair loss.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Transgender individuals can maintain stable kidney function post-transplant with gender-affirming care, but need careful management of hormone therapy risks and regular health screenings.

Dermatopathologists must consider both birth sex and gender identity to accurately diagnose and treat transgender patients.

Transgender patients use hair restoration surgery to match their hairline with their gender identity.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.